FMA Advisory’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | $2.71M | Buy |
62,945
+2,582
| +4% | +$111K | 1.01% | 34 |
|
|
2021
Q2 | $2.36M | Buy |
60,363
+1,345
| +2% | +$52.7K | 0.88% | 44 |
|
|
2021
Q1 | $2.14M | Buy |
59,018
+1,024
| +2% | +$37.1K | 0.66% | 56 |
|
|
2020
Q4 | $2.14M | Sell |
57,994
-4,783
| -8% | -$176K | 0.71% | 48 |
|
|
2020
Q3 | $2.19M | Buy |
62,777
+4,438
| +8% | +$155K | 0.87% | 40 |
|
|
2020
Q2 | $1.81M | Buy |
58,339
+1,642
| +3% | +$50.9K | 0.81% | 42 |
|
|
2020
Q1 | $1.76M | Buy |
56,697
+3,016
| +6% | +$93.4K | 0.95% | 38 |
|
|
2019
Q4 | $2M | Buy |
53,681
+5,474
| +11% | +$203K | 0.8% | 46 |
|
|
2019
Q3 | $1.64M | Sell |
48,207
-2,616
| -5% | -$89.2K | 0.71% | 49 |
|
|
2019
Q2 | $2.09M | Sell |
50,823
-202
| -0.4% | -$8.3K | 0.93% | 42 |
|
|
2019
Q1 | $2.06M | Sell |
51,025
-796
| -2% | -$32.1K | 0.94% | 40 |
|
|
2018
Q4 | $2.15M | Buy |
51,821
+452
| +0.9% | +$18.7K | 1.11% | 28 |
|
|
2018
Q3 | $2.15M | Buy |
51,369
+208
| +0.4% | +$8.7K | 0.96% | 39 |
|
|
2018
Q2 | $1.76M | Buy |
51,161
+284
| +0.6% | +$9.78K | 0.83% | 47 |
|
|
2018
Q1 | $1.71M | Buy |
50,877
+517
| +1% | +$17.4K | 0.83% | 44 |
|
|
2017
Q4 | $1.73M | Buy |
50,360
+2,975
| +6% | +$102K | 0.81% | 43 |
|
|
2017
Q3 | $1.6M | Sell |
47,385
-207
| -0.4% | -$7.01K | 0.94% | 38 |
|
|
2017
Q2 | $1.52K | Sell |
47,592
-1,481
| -3% | -$47 | 0.78% | 39 |
|
|
2017
Q1 | $1.59M | Buy |
+49,073
| New | +$1.59M | 0.81% | 44 |
|
|
2015
Q2 | $179K | Buy |
+5,624
| New | +$179K | 0.11% | 119 |
|
|
2014
Q4 | $518K | Sell |
17,517
-3,174
| -15% | -$93.9K | 0.18% | 119 |
|
|
2014
Q3 | $580K | Sell |
20,691
-1,976
| -9% | -$55.4K | 0.21% | 113 |
|
|
2014
Q2 | $638K | Buy |
22,667
+1,389
| +7% | +$39.1K | 0.23% | 108 |
|
|
2014
Q1 | $648K | Buy |
21,278
+295
| +1% | +$8.98K | 0.25% | 108 |
|
|
2013
Q4 | $610K | Buy |
20,983
+43
| +0.2% | +$1.25K | 0.25% | 104 |
|
|
2013
Q3 | $571K | Buy |
20,940
+253
| +1% | +$6.9K | 0.23% | 116 |
|
|
2013
Q2 | $550K | Buy |
+20,687
| New | +$550K | 0.23% | 115 |
|